Intermittent preventive treatment in infants - Adjusting expectations and seeing opportunity

Journal of Infectious Diseases

Volumn 194, Issue 3, 2006, Pages 269-272

  Ter Kuile, Feiko O ^a,b   Steketee, Richard W ^c,d  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c Malaria Control and Evaluation Partnership in Africa   (France)

^d Batiment Avant Centre ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; FANSIDAR; INSECTICIDE; PYRIMETHAMINE; SULFADOXINE;

AFRICA; ANEMIA; BED NET; CHEMOPROPHYLAXIS; COST EFFECTIVENESS ANALYSIS; DIARRHEA; DRUG EFFICACY; DRUG HALF LIFE; DRUG INTERMITTENT THERAPY; DRUG RESISTANCE; DRUG SAFETY; EDITORIAL; GHANA; HIGH RISK INFANT; HOSPITAL ADMISSION; HUMAN; IMMUNIZATION; INCIDENCE; INFANT; LOW BIRTH WEIGHT; MALARIA; MATERNAL ANEMIA; MOZAMBIQUE; PARASITE TRANSMISSION; PATIENT COMPLIANCE; PREGNANT WOMAN; PRESCHOOL CHILD; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; REBOUND; RESPIRATORY TRACT DISEASE; SEASONAL VARIATION; SPLENOMEGALY; TANZANIA; VECTOR CONTROL;

ANTIMALARIALS; CHEMOPREVENTION; DRUG COMBINATIONS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALARIA; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PYRIMETHAMINE; SULFADOXINE;

EID: 33746337968     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/505434     Document Type: Editorial

References (8)

1. World Health Organization Regional Office for Africa (WHO/AFRO). A strategic framework for malaria prevention and control during pregnancy in the African region. Brazzaville: WHO/ AFRO, 2004.
2. Schellenberg D, Menendez C, Kahigwa E, et al. Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial. Lancet 2001; 357:1471-7.
3. Massaga JJ, Kitua AY, Lemnge MM, et al. Effect of intermittent treatment with amodiaquine on anaemia and malarial fevers in infants in Tanzania: a randomised placebo-controlled trial. Lancet 2003; 361:1853-60.
4. Egan A, Crawley J, Schellenberg D. Intermittent preventive treatment for malaria control in infants: moving towards evidence-based policy and public health action. Trop Med Int Health 2005; 10:815-7.
5. Macete E, Aide P, Aponte JJ, et al. Intermittent preventive treatment for malaria control administered at the time of routine vaccinations in Mozambican infants: a randomized, placebo-controlled trial. J Infect Dis 2006; 194: 276-85 (in this issue).
6. Schellenberg D, Menendez C, Aponte JJ, et al. Intermittent preventive antimalarial treatment for Tanzanian infants: follow-up to age 2 years of a randomised, placebo-controlled trial. Lancet 2005; 365:1481-3.
7. Chandramohan D, Owusu-Agyei S, Carneiro I, et al. Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana. BMJ 2005; 331:727-33.
8. O'Meara WP, Smith DL, McKenzie FE. Potential impact of intermittent preventive treatment (IPT) on spread of drug-resistant malaria. PLoS Med 2006;3:e141.